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Effective pain treatment in laboratory animals undergoing 
surgical procedures is essential from an ethical standpoint, 
because pain and stress affect animal welfare detrimentally. In 
addition, pain may entail negative physiologic consequences, 
which can become significant confounders in research, by in-
creasing inter- and intraanimal variation and potentially leading 
to inaccurate results.10,12,14
Continuous refinement of pain management in laboratory 
mice involves increasing the spectrum of analgesics available 
for this species; optimizing analgesic dose regimens (dose, 
frequency, and duration); implementing new methods of admin-
istration (sustain-released formulations, voluntary ingestion); 
and developing new methods for pain assessment.
Tramadol is a centrally acting synthetic opioid, structurally 
related to morphine and codeine2,18,33 and used for the treatment 
of moderate to severe pain, both acute and chronic, in various 
species, including humans.21 Tramadol has some selectivity for 
the μ receptor and binds weakly to κ and δ receptors; further-
more, tramadol activates the monoaminergic system, inhibiting 
neuronal reuptake of serotonin (5-hydroxytryptamine) and 
noradrenaline (norepinephrine).3,27 The clinical efficacy of 
tramadol is highly related to its first metabolite, O-demethyl-
tramadol hydrochloride (M1), which has 200-fold higher affinity 
for μ receptors and as much as 6-fold higher analgesic potency 
than tramadol itself.25,30 Because of its ‘double’ mechanism of 
action, tramadol at clinical doses does not induce respiratory 
depression or hemodynamic changes, which are common to 
other opioids with high μ-receptor activity.9,21,26 Moreover, 
tramadol is an affordable and non-controlled substance in many 
countries, thus facilitating its use.
Published data regarding the pharmacokinetics, dose regi-
mens, and analgesic efficacy of tramadol in mice are few, and 
the evidence available is, at best, controversial. One study24 
demonstrated that tramadol ameliorates cyclophosphamide-
induced bladder-pain-related behaviors in mice, whereas 
another31 found that tramadol did not reduce symptoms of 
postsurgical pain after abdominal laparotomy in mice. However, 
in the laparotomy study,31 the drug was injected every 12 h, 
which is likely to have been insufficient for effective pain relief.
The administration of drugs through voluntary ingestion in 
laboratory rodents has gained popularity in recent years, be-
cause this method reduces the handling stress that accompanies 
intraperitoneal and subcutaneous injections—hitherto the most 
common routes used in mice.7,8,29 Voluntary consumption of 
buprenorphine, for example, in food items and drinking water 
results in high serum concentrations with significant antinoci-
ception and a longer duration of action in rats than the widely 
recommended subcutaneous route.17 Conversely, in mice, bu-
prenorphine self-administration through drinking water might 
lead to variable and low blood concentrations of the drug during 
the animals’ resting phase, thus perhaps necessitating additional 
doses to reach therapeutically effective drug levels.28 However, 
studies from our laboratory have shown that self-administration 
of 25 mg/kg tramadol in drinking water resulted in high and 
stable plasma levels of drug in naïve C57BL/6J mice throughout 
the consumption time (including the animals’ resting phase), 
with levels decreasing rapidly after administration ceased.4
In the present study, we hypothesized that a subcutaneous 
injection of tramadol (25 mg/kg) followed by voluntary inges-
tion of tramadol in drinking water (25 mg/kg) over 24 h would 
Analgesic Efficacy of Subcutaneous–Oral Dosage 
of Tramadol after Surgery in C57BL/6J Mice
Rocio Evangelista-Vaz,1 Alessandra Bergadano,2 Margarete Arras,3 and Paulin D Jirkof3,*
This study investigated the analgesic activity of tramadol in female C57BL/6J mice by using a single subcutaneous injection 
(25 mg/kg) of tramadol combined with the same dose given in drinking water for 24 h. We then evaluated the pharmacokinet-
ics of tramadol and its active metabolite O-demethyltramadol (M1). To evaluate pain and analgesic efficacy, we performed 
clinical and behavioral assessment, burrowing tests, and activity analysis and measured body weight, food and water intake 
in mice that were untreated (control) or underwent analgesia only (T); anesthesia and surgery (AS); or anesthesia, surgery, 
and analgesia (AS+T). The plasma concentration of tramadol decreased rapidly whereas, for more than 18 h, the M1 level 
remained stable and above its minimal analgesic concentration for humans. Total food and water intake over 24 h was com-
parable among all groups. Although T mice consumed tramadol-treated water in sufficient amount and frequency, AS and 
AS+T animals showed decreased drinking frequency during the first 4 h after surgery. Compared with control and T groups, 
composite pain scores and burrowing latencies increased significantly in both AS and AS+T mice after surgery, suggesting 
postsurgical pain. However, AS and AS+T mice did not differ significantly after surgery. In conclusion, although naïve ani-
mals ingested a sufficient amount of the drug and plasma levels appeared sufficiently high, mice markedly reduced water 
intake immediately after surgery. Consequently, even in combination with an initial drug injection, the subsequent voluntary 
tramadol intake was insufficient to reduce signs of postsurgical pain significantly after laparotomy.
DOI: 10.30802/AALAS-JAALAS-17-000118
Received: 22 Sep 2017. Revision requested: 24 Oct 2017. Accepted: 20 Dec 2017.
1Discovery Oncology Pharmacology and 2Comparative Medicine, Roche Pharma Re-
search and Early Development, Roche Innovation Center Basel, Basel, Switzerland; 
and 3Division of Surgical Research, University Hospital Zurich, University of Zurich, 
Zurich, Switzerland
*Corresponding author. Email: Paulin.Jirkof@usz.ch
jaalas17000118.indd   368 7/12/2018   1:50:24 PM
369
Postsurgical subcutaneous–oral tramadol analgesia in B6 mice
provide effective postoperative analgesia in C57BL/6J mice un-
dergoing unilateral sham embryo transfer surgery. We assessed 
the efficacy of the chosen analgesic protocol by 1) evaluating 
clinical and behavioral markers of pain; 2) measuring body 
weight and food and water intake; 3) performing burrowing 
tests; and 4) generating a pharmacokinetic profile.
Materials and Methods
Ethics statement. The Cantonal Veterinary Office (Zurich, 
Switzerland) approved the animal housing and experimental 
protocols under license no. ZH 181/2012; procedures were in 
accordance with Swiss Animal Protection Law and conform to 
European Directive 2010/63/EU of the European Parliament 
and the Council on the Protection of the Animals used for Scien-
tific Purposes and to the Guide for the Care and Use of Laboratory 
Animals, 8th edition (Council 2011).13
Animals and standard housing conditions. Female C57BL/6J 
mice (n = 64; age, 6 to 8 wk; weight, 18 to 22 g) were obtained 
from a commercial supplier (Charles River, L’Arbresle, France). 
Female animals were used for comparability with previous 
studies (for example, references 14 and 26). The animals’ 
health status was monitored by a health surveillance program 
according to the Federation of European Laboratory Animal 
Science Associations (FELASA) guidelines. The mice were 
free of all viral, bacterial, and parasitic pathogens listed in the 
FELASA recommendations22 (mouse hepatitis virus, mouse 
rotavirus, murine norovirus, minute virus of mice, mouse par-
vovirus, Theiler murine encephalomyelitis virus, lymphocytic 
choriomeningitis virus, mouse adenovirus type 1 [FL], mouse 
adenovirus type 2 [K87], mousepox [ectromelia] virus, pneu-
monia virus of mice, reovirus type 3, Sendai virus, Helicobacter 
spp., Pasteurella pneumotropica, β-hemolytic streptococci, Strep-
tococcus pneumonia, Citrobacter rodentium, Clostridium piliforme, 
Corynebacterium kutscheri, Mycoplasma pulmonis, Salmonella spp., 
Streptobacillus moniliformis, and endo- and ectoparasites).
Mice were housed in groups of 4 to 8 for 3 wk prior to the 
beginning of the experimental phase. The animals were kept 
in conventional transparent plastic cages (Eurotype III, Techni-
plast, Hohenpeißenberg, Germany) with autoclaved dust-free 
sawdust bedding (80 to 90 g per cage; LTE E-001, Abedd, 
Indulab, Gams, Switzerland), hay (8 to 12 g per cage; Win-
zeler, Affoltern am Albis, Switzerland), and cardboard shelters 
(Ketchum Manufacturing, Brockville, Ontario, Canada). They 
were fed a pelleted and extruded mouse diet (no. 3436, Provimi 
Kliba, Kaiseraugst, Switzerland) without restriction and had 
unrestricted access to drinking water. The room was maintained 
on a 12:12-h light:dark cycle with artificial light (approximately 
40 lx in the cage). The temperature was 21 ± 1 °C, with a rela-
tive humidity of 55% ± 10%. Animals were handled by the tail. 
Disturbances (that is, unrelated experimental procedures) were 
not allowed in the housing room.
Analgesic protocols. The analgesic protocol used was 
tramadol hydrochloride (25 mg/kg SC; Tramal 100 injection, 
Grunenthal, Stolberg, Germany) administered 10 to 20 min 
before surgery, followed by tramadol in drinking water (25 
mg/kg), beginning 1 h after the injection and continuing for 
24 h. Shortly before injection, tramadol was diluted in sterile 
NaCl 0.9% (B Braun Medical, Sempach, Switzerland) so that 
the injection volume was 0.04 mL per 10 g body weight. Bottles 
containing tramadol in drinking water were prepared shortly 
before surgery and had a final concentration of 0.2 mg/mL.
Experimental design, experimental animal housing condi-
tions, and data acquisition. Mice were randomly (complete 
and blinded randomization) assigned to 1 of the 2 behavioral 
assessment settings and 1 of 4 experimental groups (n = 8 per 
setting and group): controls (naïve, no manipulation); T group, 
(tramadol injection followed by tramadol in drinking water for 
24 h); AS group, mice underwent surgery and anesthesia with-
out analgesic treatment but received an injection of saline; or 
AS+T group, mice underwent anesthesia, surgery, and analgesia 
with tramadol as described earlier.
Behavioral assessment involved 2 experimental settings and 
was performed after surgery or respective control procedures: 
1) burrowing test and clinical assessment in a standard cage,16 
or 2) automated activity analysis and measurement of food and 
water intake and body weight in an observation cage. Mice were 
housed individually in one of these settings for 2 d before and 
1 d after experimental intervention.
For the surgical procedure, the experiments began 60 to 90 
min before the start of the dark phase, the active phase of the 
mice. The fur at the surgical site was clipped, and the mice re-
ceived a subcutaneous injection of tramadol or saline. At 10 to 
20 min after injection, the animals were transferred in individual 
transport cages to an operating theater and anesthetized with 
sevoflurane (Sevorane, Abbot, Baar, Switzerland) as monoan-
aesthesia. The anesthetic gas was provided by using a rodent 
inhalation anesthesia system (Provet, Lyssach, Switzerland); 
oxygen was the carrier gas. The mice were placed on a warm-
ing mat (TP500, Gaymar, Orchard Park, NY) set at 39 ± 1 °C to 
ensure constant body temperature, and anesthesia was induced 
and maintained through a nose mask (8% and 6% sevoflurane 
at 600 mL/min gas flow, respectively). The surgical site was 
disinfected with chlorhexidine.
Mice in surgery groups underwent a one-sided sham embryo 
transfer procedure under aseptic technique. The skin in the 
mouse’s left flank was incised vertically approximately 2 fingers 
cranial to the tail root, with a length of approximately 0.5 cm. 
The subcutis was cut and the abdominal muscle was incised. 
The underlying fat was lifted, exposing the ovary. The ovary was 
then elevated, thus stretching the ligaments to mimic the embryo 
transfer procedure. After relocation of the ovary, the incision in 
the abdominal muscle wall was closed with absorbable suture 
(6-0 polyglycolic acid suture, Ethicon, Norderstedt, Germany), 
and the skin was closed by using skin staples (Precise, 3M Health 
Care, St Paul, MN). Surgery was completed within 3 to 4 min, 
and anesthesia lasted 6 to 8 min. Mice (while moving freely in 
their transport cages) were allowed to recover for 30 to 40 min 
in a warming cabinet set at 32 °C. Then they were returned to 
their home cages.
Setting 1. Clinical and behavioral assessment. For clinical 
investigation and behavior-based pain assessment, mice were 
placed individually in a small acrylic observation chamber 
(10 × 10 × 10 cm), where each animal was observed for 4 min. 
Observations took place at 1 and 4 h after tramadol or saline 
injection, or at comparable time points for control animals. Scor-
ing was performed according to a system that documented the 
general condition, indicators of abdominal pain, and changes 
in facial expression.16 Clinical signs were then converted into 
numerical scores according to a scoring system (Figure 1) and 
summed to obtain a composite score for each animal. Investi-
gators performing behavioral testing (PJ, RE) were blinded for 
treatment groups.
Burrowing test. The burrowing test uses the natural burrow 
digging and cleaning behavior of mice and determines spon-
taneous burrowing activity. Assessing burrowing latencies can 
be used as a simple method to assess postsurgical impairment 
and pain in mice. Standard cages contained a pellet-filled water 
bottle in one corner of the cage.15 Cages were videorecorded 
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from above by using infrared-sensitive cameras (Ikegami, 
Tokyo, Japan). The latency of each animal to burrow (the 
removal of more than 3 pellets within 10 s) was assessed by 
analyzing videorecordings taken during the first 12 h after the 
return of the animal to its home cage (1 h after completion of 
surgery), or at a comparable time point for control and T ani-
mals. Investigators analyzing the videorecordings (PJ, RE) were 
blinded for treatment groups.
Setting 2. Activity analysis. Observation cages were video-
recorded for 24 h, starting 1 h after the end of surgery or at a 
comparable time point, from above by using infrared-sensitive 
cameras for analysis of home-cage activity by using automated 
tracking software (EthoVision XT 7, Noldus Information Tech-
nology, Wageningen, Netherlands). The distance (in centimeters) 
over which the center point of the animal moved was assessed 
to measure static behaviors as well as horizontal locomotion.
Body weight and food and water intake. The animals, food 
pellets, and water bottles were weighed directly before and 24 
h after the procedures. A blinded observer viewing the vide-
otapes counted the drinking events during the first 4 h after the 
return of the mouse to its home cage, or at a comparable time 
point for control animals.
Serum levels and calculation of maximal plasma concentra-
tion. After a washout phase (at least 2 wk), 42 randomly selected 
mice were reused for establishing the pharmacokinetic profile of 
tramadol. The animals used for pharmacokinetic profiling were 
housed in groups of 8 in standard cages, as described earlier; 
6 mice were used for each time point (1, 2, 4, 12, 18, 24, and 28 
h after subcutaneous administration of tramadol, and continu-
ous administration in drinking water). Mice underwent deep 
terminal anesthesia with sevoflurane, and blood was collected 
by cardiocentesis. Blood was centrifuged, and the plasma was 
stored at –20 °C until further analysis. Plasma concentrations 
of tramadol and M1 were determined by HPLC followed by 
tandem mass spectrometry at a commercial laboratory (Toxilab 
Ludwigsburg, Laboratory for Toxicology and Drug Evalua-
tions, Ludwigsburg, Germany). Peak plasma concentration was 
calculated by using appropriate software (Phoenix WinNonlin 
Version 6.4; Pharsight Corp., CA).
Statistical analyses. Power calculation for group size determi-
nation was performed by using G*Power 3.15 Statistical analyses 
were performed by using Prism 6 (GraphPad Software, La Jolla, 
CA) and SPSS 23 (IBM, Armonk, NY). All data were tested for 
normal distribution and homogeneity of variance (Shapiro–
Wilks and Levene tests). Means and SD were calculated for all 
parameters. Univariate ANCOVA were performed for body 
weight, changes in the weights of food pellets and water bottles 
(with corresponding baseline values as covariates) followed by 
post hoc tests (Bonferroni). Composite scores, as well as distance 
moved during 24 h of activity analyses, were evaluated through 
one-way ANOVA followed by post hoc tests (Bonferroni) to 
show significant differences between groups. Kaplan–Meier 
survival analysis was performed to examine the distribution of 
time to effect (latency to burrow). To test whether the latency 
to burrow differed between treatment groups, a log-rank sig-
nificance test was performed. The threshold for significance in 
all statistical tests was set at a P value of 0.05.
Results
Setting 1. Clinical assessment. Observation of the mice 
revealed no physical complications from the surgical proce-
dures performed (that is, open wounds) or of the analgesic 
treatment (that is, skin irritation at the injection site). During 
the observation time, none of the mice bit or manipulated their 
incision sites.
Composite scores differed significantly after 1 h (P < 0.0001, 
df = 3, F = 11.25) and 4 h (P = 0.001, df = 3, F = 6.992). Compared 
with control scores, composite score means were increased in 
all experimental groups (Figure 2). Animals that underwent 
Figure 1. Scoring system for clinical investigation and behavior-based pain assessment. In total, a maximal score of 15 can be reached. Each 
mouse was observed for 4 min.
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Figure 3. Survival analysis for burrowing latencies. The graph shows 
the survival percentage of mice that had not yet started to burrow as 
distributed over time. Burrowing latencies in control animals were 
short. Tramadol treatment alone increased latency to burrow non-
significantly compared with control latency. Burrowing latencies were 
prolonged significantly after surgery with and without analgesia with 
tramadol compared with control latency. No significant differences 
were observed between experimental groups, except for AS+T com-
pared with T. All groups contained 8 mice. T, analgesia with subcuta-
neous tramadol followed by tramadol in drinking water; AS+T, sur-
gery and anesthesia and analgesia; AS, surgery and anesthesia (mice 
underwent anesthesia and surgery without analgesic treatment).
surgery, with or without analgesic treatment, achieved higher 
composite scores than those for control or T group scores, thus 
suggesting postsurgical pain. These differences were significant 
at 1 h for the comparison of AS and AS+T groups with controls 
(P < 0.001 and P = 0.016, respectively) and for T compared with 
AS (P = 0.006). At 4 h, the scores of both surgery groups were 
significantly greater than the control score (AS, P = 0.022; AS+T, 
P = 0.012) and the T group score (AS, P = 0.028; AS+T, P = 0.016).
Despite the lack of significant differences between the com-
posite scores of groups that underwent surgery with or without 
analgesia, we noted some interesting, albeit nonsignificant, ten-
dencies in the individual scoring units. For example, hunched 
posture and decreased fur condition occurred in all experimen-
tal groups except for control animals, whereas all animals that 
underwent surgery, regardless of analgesic treatment, showed 
increased orbital tightening and rotation of the ears. Stretching 
and pressing movements were more frequent in the AS group 
(that is, no analgesia).
By 4 h after surgery, the general appearance of the mice (fur, 
posture, and so forth) had normalized in all groups. Grooming 
was observed from 1 h onward, and all mice showed normal 
periods of activity followed by periods of resting.
Burrowing test. Burrowing latencies in control animals (7.5 ± 
5.5 min) and after tramadol treatment alone (21.34 ± 17.14 min; 
P = 0.0513 compared with control) were short. Compared with 
control, burrowing latencies were prolonged significantly after 
surgery with and without analgesia (AS+T: 214.9 ± 78.3 min, 
P = 0.0002; AS: 191.9 ± 135.7 min, P = 0.0015), thus suggesting 
postsurgical pain. Burrowing latency did not differ between 
experimental groups, except for AS+T compared with T (P = 
0.0155; Figure 3).
Setting 2. Activity analysis. Mean center point movement 
was comparable between groups that did not undergo surgery 
(control, 1477.49 ± 137.97 m; T, 1252.33 ± 81.18 m, respectively, 
P = 0.18), whereas groups undergoing surgery showed decreased 
activity. However, the decrease in mean distance was significant 
only for the AS+T group (1259.85 ± 67.89 m) compared with both 
the controls (P < 0.001) and T group (P = 0.0002).
Body weight and food and water intakes. Compared with the 
control group (17.7 ± 0.7 g before procedures compared with 
17.9 ± 0.8 g afterward), all treated groups showed a decrease in 
body weight after experiments (T, 19.1 ± 0.8 g compared with 
18.7 ± 0.7 g; AS, 20.6 ± 1.7 g compared with 20.1 ± 1.8 g; and 
AS+T, 20.1 ± 2.4 g compared with 19.4 ± 2.3 g). Treatment had a 
significant effect on experimental body weight after correction 
for baseline body weight (F3, 25 = 3.985, P = 0.019, partial η
2 = 
0.323). Post hoc tests revealed a significant (P = 0.018) difference 
in body weight between the control and AS+T groups.
Food intake decreased slightly in all groups after experiments 
(control, 3.8 ± 0.3 g compared with 3.2 ± 0.3 g; T, 3.4 ± 0.4 g com-
pared with 3.1 ± 0.4 g; AS, 3.8 ± 0.6 g compared with 3.1 ± 0.8 g; 
and AS+T, 3.4 ± 0.5 g compared with 2.3 ± 0.7g). Treatment had 
a significant effect on postprocedural food intake after correct-
ing for baseline food intake (F3, 27 = 3.729, P = 0.023, partial η
2 = 
0.293). Post hoc tests revealed a significant (P = 0.04) difference 
in food intake between the T and AS+T groups.
In most groups, water intake was nonsignificantly lower after 
experiments (control, 5.1 ± 0.9 g compared with 4.9 ± 0.8 g; T, 4.5 
± 0.3 g compared with 4.3 ± 0.5 g; AS, 5.0 ± 0.7 g compared with 
4.8 ± 1.7 g; and AS+T, 4.5 ± 0.5 compared with 4.5 ± 2 g). After 
correction for baseline intake, treatment had no effect on water 
intake after procedures (F3, 27 = 0.208, P = 0.890, partial η
2 = 0.023).
Drinking event frequency during the first 4 h was comparable 
between control (20 ± 5 events) and T (20 ± 8 events) groups but 
appeared reduced in AS (6 ± 2 events) and AS+T (7 ± 3 events) 
groups (Figure 4).
Serum concentrations of tramadol and M1. In naïve mice, 
serum concentrations of tramadol were high (maximum, 670 
Figure 2. Composite scores (mean ± 1 SD) at 1 and 4 h after recovery 
from anesthesia (or at comparable time points in T and control mice). 
Compared with those in controls, composite scores were increased in 
all experimental groups. Mice that underwent surgery, with or without 
analgesic treatment, reached higher composite scores than control or T 
mice; at 1 h, these differences were significant between AS and AS+T 
groups compared with controls and between T and AS mice. At 4 h 
the scores of both the AS and AS+T groups differed significantly from 
the control and T group scores.  Significantly (P ≤ 0.05) different from 
acontrol or b T groups. All groups contained 8 mice. T, subcutaneous 
tramadol followed by tramadol in drinking water; AS+T, surgery and 
anesthesia and analgesia; AS, surgery and anesthesia (mice underwent 
anesthesia and surgery without analgesic treatment).
jaalas17000118.indd   371 7/12/2018   1:50:25 PM
372
Vol 57, No 4
Journal of the American Association for Laboratory Animal Science
July 2018
± 359 ng/mL) during the first hour of administration. The 
concentration of tramadol then decreased rapidly during the 
first 2 h after treatment to levels below the minimal analgesic 
concentration established in humans (100 ng/mL). In contrast, 
the highest serum concentrations of M1 occurred at 1 h after 
subcutaneous administration of tramadol (2460 ± 478 ng/mL) 
and remained above the minimal analgesic concentration for 
humans (40 ng/mL)20 until 18 h after tramadol administration 
began (Figure 5).
Discussion
The aim of the present study was to explore whether 
the combination of a single subcutaneous injection of trama-
dol (25 mg/kg) followed by voluntary ingested tramadol 
(25 mg/kg over 24 h in drinking water) offered reliable an-
algesic coverage in a clinical relevant mouse model of mild 
surgical pain.
Previous pharmacokinetic data from our lab indicated that 
presurgical injection of tramadol would be sufficient to provide 
perioperative analgesia for at least 1.5 to 2 h and that continuous 
postoperative analgesia would be achieved by providing trama-
dol in the drinking water.4 The analgesic potency of tramadol is 
appropriate for mild to moderate pain.21 The analgesic efficacy 
Figure 4. Drinking event frequency during the first 4 h was compa-
rable between control and T groups but reduced in AS and AS+T 
groups. Each row of dots represents the drinking events for an indi-
vidual mouse. Data are solely descriptive; no statistical analysis was 
applied. All groups contained 8 mice. T, analgesia with subcutaneous 
tramadol followed by tramadol in drinking water; AS+T, surgery and 
anesthesia and analgesia; AS, surgery and anesthesia (mice under-
went anesthesia and surgery without analgesic treatment).
Figure 5. (A) Semilog plot of serum tramadol concentrations (mean ± 
1 SD) over time after subcutaneous injection of 25 mg/kg tramadol 
followed by 25 mg/kg tramadol in drinking water for 24 h. The hori-
zontal line represents the minimal analgesic concentration of tramadol 
in humans (100 ng/mL). (B) Semilog plot of serum M1 concentrations 
(mean ± 1 SD) over time after subcutaneous administration of 25 mg/kg 
tramadol followed by 25 mg/kg tramadol in drinking water for 24 h. 
The horizontal line represents the minimal analgesic concentration of 
M1 in humans (40 ng/mL) in humans.
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of tramadol depends on the parent compound and on its first 
metabolite, which is as much as 6 times more potent than trama-
dol itself.25,30 Although the serum concentrations of tramadol in 
our mice decreased rapidly, the levels of M1 remained high for 
18 h in our study, and we, therefore, expect an analgesic effect 
from the tested treatment.
We chose the unilateral sham embryo-transfer surgery 
model, which elicits mild to moderate pain, based on ethical 
grounds—to avoid using a more severe surgical procedure in 
the light of unconfirmed analgesic efficacy—and in light of 
the spread and relevance of this intervention (laparotomy for 
embryo transfer) in female laboratory mice.19,23 The recognition 
of mild to moderate pain in mice can be challenging because 
mice typically mask overt signs of pain or discomfort. We 
therefore used clinical monitoring tools as well as sensitive 
behavior-based pain indicators to assess pain and analgesic 
efficacy in the current study.6,15,16,23,32 Even though the pain 
induced in our study was likely mild in nature, our behavior-
based pain scoring methods detected a clear and significant 
effect of surgery. The observed decrease of pain signs at 4 h 
after surgery supports the expected duration of postsurgical 
pain in the laparotomy model used.
Home-cage observations revealed that mice that received 
tramadol but underwent no further experimental procedures 
willingly drank the calculated dose of tramadol during the 
24-h time period (approximately 25 mg/kg). During the first 4 
h of the experiment, this intake was frequent and regular and 
is therefore in agreement with the pharmacokinetic analyses 
mentioned. Nevertheless, even though total intake of water 
for 24 h remained stable in all experimental groups and oral 
analgesia administration was initiated during the activity phase 
of mice, when mice normally drink frequently and regularly,28 
drinking water intake in mice that underwent anesthesia and 
surgery was less regular and frequent during the immediate 
postsurgical phase, that is the first 4 h after surgery, compared 
with control and T groups. This effect might be due to the in-
fluence of surgery and anesthesia procedures on the animals’ 
behavior. Because the first few hours after surgery are probably 
the period of highest pain levels, a reduction in drinking fre-
quency and thus likely also in water intake, might interfere with 
the efficacy of an analgesia protocol, particularly one involving 
a short-acting drug like tramadol. Consequently, we observed 
signs of unrelieved pain, that is prolonged burrowing latencies 
and increased composite pain scores, not only in animals that 
underwent surgery without pain treatment but also in mice 
that received the combination treatment of injected and oral 
tramadol perioperatively.
Burrowing latency is increased by postsurgical pain in mice.15 
However, an increase in the latency to burrow has been also 
reported in animals treated with buprenorphine only,16 due to 
increased locomotor activity, a well-known adverse effect of 
buprenorphine.11 The effect of tramadol on burrowing activity 
was unlikely due to changes in general activity, given that the 
administration of tramadol in the absence of surgery did not 
alter 24-h home-cage locomotion. However, burrowing latency 
was increased significantly in both surgery groups, hinting 
that this tramadol dose failed to provide sufficient pain relief. 
Similarly, composite pain scores were significantly increased in 
both surgery groups compared with controls.
Monitored clinical signs were affected in all experimental 
groups, suggesting general effects of anesthesia, surgery, and 
tramadol itself on wellbeing. Whereas all mice that underwent 
surgery, regardless of analgesic treatment, showed approxi-
mately the same level of increased orbital tightening and 
rotation of the ears, mice in the AS group (that is, without an-
algesia) more frequently demonstrated stretching and pressing 
movements were observed more. These behavior results sug-
gest the higher pain specificity of these assessment parameters 
compared with more general clinical signs. Although these 
behaviors, especially the press and stretch events, were too 
rare for statistical analysis, this observation suggests that the 
analgesic treatment had some effect on signs of pain specific for 
this model of surgery (abdominal laparotomy). Consequently, 
the tramadol protocol used may have achieved partial albeit 
insufficient pain relief in the tested model. We are unable to 
discriminate the effects of anesthesia on the behavioral results 
from the pain effects here, but other studies suggest that the 
effect of inhalation anesthesia on the read-out of the applied 
test can be controlled.15,16
The lack of significant differences in pain measures between 
the AS and AS+T groups may be due to the high interindividual 
variability in both surgery groups. In turn, this interindividual 
variability might at least partially be explained by the irregular 
and variable oral intake of tramadol after surgery. Alterna-
tively, the dose we selected, although based on previous PK 
data,4 might have been too low to reach an effective blood 
concentration of tramadol and M1 in mice. To date, target 
blood concentrations are known for humans only and may not 
be directly translatable to mice. The preemptive subcutaneous 
injection of 25 mg/kg tramadol before surgery has a presum-
able postsurgical duration of action of 2 to 4 h4 and is therefore 
insufficient to bypass a potentially reduced intake or potential 
lack of efficacy of voluntary ingested tramadol. Moreover, the 
increased composite scores in the AS+T group at 1 h suggest 
that the subcutaneous injection might also have failed to suf-
ficiently relieve acute postsurgical pain; this finding might again 
hint at the insufficient analgesic action of tramadol at the dose 
analyzed in our model.
In addition to the moderate effects of tramadol on the behav-
ioral pain assessment parameters we used here, other side effects 
of opioids might be expected. For example, opioids frequently 
decrease water and food intake in rodents and consequently 
reduce body weight, an effect that has frequently been ascribed 
to buprenorphine1 and one that might be detrimental in the 
postsurgical recovery period. In the present study, body weight 
and total food and water intake over 24 h were similar among 
all experimental groups and differed only slightly compared 
with control animals. This effect included animals that received 
tramadol but that did not undergo surgery. Therefore, tramadol 
shows probably less severe behavioral side effects than the 
popular buprenorphine.
In conclusion, the analgesia protocol chosen, consisting of a 
single subcutaneous injection of tramadol at 25 mg/kg followed 
by tramadol at 25 mg/kg in drinking water for 24 h does not 
appear to provide full or sufficient analgesic coverage for the 
treatment of mild to moderate postsurgical, abdominal pain. 
The lack of efficacy might be due to high interindividual vari-
ability in the intake of treated drinking water,28 to the observed 
reduction of drinking frequency during the postsurgical phase, 
or to an insufficient dose. However, even though the differ-
ences were not significant, composite pain scores were slightly 
lower in tramadol-treated as compared with untreated operated 
mice. This result is promising and encourages the completion 
of additional studies to find better and more reliable tramadol 
protocols for mice.
Therefore, as next steps, it is necessary to establish the thera-
peutically effective dose of tramadol and its serum concentration 
in mice and to confirm that opioid-related side effects remain 
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low when doses are increased. Furthermore, because sexes and 
mouse strains and lines may differ in regard to nociception and 
in response to different analgesics, the analgesic efficacy of 
tramadol must be evaluated in males and different mouse strains 
before it is used routinely for postsurgical analgesia in mice.
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